FilingReader Intelligence
Astec LifeSciences loss widens to ₹330.6m in Q1
July 28, 2025 at 09:59 AM UTC•By FilingReader AI
Astec LifeSciences reported a standalone loss before tax of ₹330.6m for the quarter ended June 30, 2025, wider than the ₹156.9m loss in the previous quarter but improved from the ₹616.7m loss in the same quarter last year. Revenue from operations was ₹910.8m.
The company completed a rights issue of 2.8m shares at ₹890 per share, raising ₹2.49bn. The issue closed on July 28, 2025.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
BSE:ASTEC•Bombay Stock Exchange
News Alerts
Get instant email alerts when ASTEC LIFESCIENCES publishes news
Free account required • Unsubscribe anytime